By Patricia Prewitt
My Personal Rx Advisor
The GLP-1 medications for weight loss are all over social media promoted by celebrities and others impressed with their quick results. Who doesn’t want to look great at an upcoming reunion or wedding? Patients have been clamoring for prescriptions only to find the costs prohibitive, unless the medical need is for Type 2 diabetes, moderate to severe sleep apnea, and or/fatty liver disease. The Centers for Medicare and Medicaid Services (CMS) recently announced a new short term access program called the CMS Medicare Bridge to help Medicare subscribers with a more affordable option.
Why won’t prescription plans approve these products for weight loss? GLP-1 medications are new, expensive, and were tested in clinical trials for specific chronic and concerning medical conditions (not weight loss) for FDA approval. Lifestyle or “vanity” prescriptions are considered non-medical in nature. Prescriptions for weight loss, hair loss, some skin products, and sexual health products are out-of-pocket costs for anyone-regardless of their prescription plan.
What is the new Medicare GLP-1 Bridge program? As of July 1 2026, CMS announced a short-term access program for patients with Medicare Part D coverage for certain GLP-1 products. The program operates outside of traditional Medicare Part D plan coverages. Eligible patients must meet certain criteria to qualify, and have a valid prescription for a specific GLP-1 product. Claims must be submitted through a specified central processor that manages prior authorization, claims processing, and pharmacy payments.
Which specific GLP-1 products are covered? Foundayo (orforglipron) Tablets, Wegovy (semaglutide) tablets and injection, and Zepbound (tirepatide) Kwikpen. The single dose Zepbound pen and vials are not covered.
What’s the price? When properly processed, the cost is a flat $50 a month. Only one month at a time may be obtained. The costs will not apply to any insurance premiums or deductibles.
What are the CMS Medicare Bridge program qualifications? The patient must be over 18 and certain body mass indexes (BMI) criteria must be met. The full criteria can be read here: https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge.
For general weight loss, a documented body mass index (BMI) of at least 35 or higher is required. For lower BMI numbers 27-34 (overweight) additional medical criteria must be met related to a diagnosis of uncontrolled hypertension, chronic kidney disease, heart failure, pre-diabetes, peripheral artery disease, or a previous myocardial infarction or stroke.
Who is excluded? If Medicare Part D patients have received coverage under their Medicare Part D plan, coverage must continue to be submitted through that plan. Certain Medicare private fee-for-service subscribers are excluded from the CMS Bridge unless they are also enrolled in a stand-alone prescription drug plan.
Can people not on Medicare access this program? No.The CMS Bridge is a short-term access program only for Medicare subscribers.
At the pharmacy counter: If the prescriber has initiated Rx access through the CMS Medicare Bridge program, the cash price should be $50 at check out. If it is not, ask for the tech to reprocess using the GLP-1 CMS Medicare Bridge to process.
Buyer beware: Social media platforms are exploding with testimonials for non-regulated compounded versions of GLP-1s. Even some gas stations and convenience stores are selling research grade peptide products! All prescription medications have risks and benefits. Initiation of any new therapy should be discussed with the prescriber for potential interactions with any other prescriptions, and known side effects. The drug class carries a Black Box warning related to thyroid C-cell tumors.
Recap: This new access program for Medicare enrollees could be beneficial for some subscribers. As with all medications, monitoring by a US-based licensed prescriber is advised to check for side effects and to make dosing adjustments.
Content provided is for education purposes only and is not intended as a substitute for advice from a qualified medical professional. The opinions expressed within are those of the author.
About the Author: Patricia Prewitt is a local Massachusetts resident who spent more than 30 years in the pharmaceutical industry. Tricia is a consumer education advocate, and loves helping people find ways to save money on their prescriptions. More information and free resources are available on her website at https://mypersonalrxadvisor.com/resources or call her at 508-507-8840. Favorite Quote: ”Act as if what you do makes a difference. It does.” – William James
